HIGH-CONTENT ANALYSIS & PHENOTYPIC SCREENING 2016
- 高容量分析与表型筛选年会 2016年 -
2016年2月11 - 12日
美国,加州,圣地亚哥,Hilton San Diego Resort & Spa

  • The Longest Running HCA Meeting
High-Content Analysis Link   Phenotypic Screening Link


关于本年会

由CHI第13次主办High-Content Analysis,不但是介绍高容量分析(HCA)应用与技术最新趋势的重要会议,今年更加入了全新议程,跟去年一样在美国加州圣地牙哥盛大举行。近年来HCA技术日趋成熟,也逐渐被导入到化合物筛选、评估、功能分析等各种领域之中。HCA年会将著重于下一阶段的科技发展,包括3D及具生理意义复合物模型的筛选、超高分辨率及高通量影像、其他先进影像分析及数据管理、以及各种新试验与应用。共同举办的第2届Phenotypic Screening将聚焦于表型筛选与标的筛选的优劣、试验开发、具生理意义模型的选择与接随而来的标的辨识、以及龙头药厂的表型筛选个案研究。与会者可参与High-Content Analysis及Phenotypic Screening的所有会议,听取最先进的研究成果发表,在展示会大厅接触最新技术,并参加用户团体会议与晚餐会等活动。

主题

  • 利用表型筛选的药物开发个案研究
  • 3D细胞培养的高容量分析与表型筛选
  • 包含类器官、器官型初代细胞、iPS细胞、球状在内的最新筛选模型
  • 试验开发与HCA领域的个案研究
  • 标的与途径的识别与验证
  • 表型筛选与高容量筛选的数据分析
  • 化学基因体学与化学蛋白质体学
  • 定量系统药理学
  • 活细胞影像技术
  • 超高分辨率影像技术

知名讲者

Paul Andrews, Ph.D.
Director, National Phenotypic Screening Centre, University of Dundee, UK

Ulrich Broeckel, M.D.
Professor, Pediatrics, Medical College of Wisconsin

Anthony M. Davies, Ph.D.
Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

Lauren Drowley, Ph.D.
Associate Principal Scientist, AstraZeneca

Su Guo, Ph.D.
Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco

Erik Hett, Ph.D.
Senior Scientist, Chemical & Molecular Therapeutics, Biogen

Susanne Heynen-Genel, Ph.D.
Director, High-Content Screening Systems, Sanford Burnham Prebys Medical Discovery Institute

Beatrice Knudsen, M.D., Ph.D.
Director, Translational Pathology, Cedars Sinai Medical Center

Ming Lei
Senior Scientist, Lead Discovery & Optimization, Bristol-Myers Squibb

Zhuyin Li, Ph.D.
Translational Biomarker Team Lead, Lead Discovery & Optimization, Bristol-Myers Squibb

David J. Logan, Ph.D.
Computational Biologist, Imaging Platform, Broad Institute of Harvard and MIT

Mary-Ann Mycek, Ph.D.
Professor and Associate Chair for Translational Research, Department of Biomedical Engineering, College of Engineering & Medical School, University of Michigan

Madhu Lal-Nag, Ph.D.
Acting Team Lead, RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Nathan Ross, Ph.D.
Senior Investigator, High Throughput Biology Group Leader, Novartis Institutes for BioMedical Research

Ulrich Schopfer, Ph.D.
Executive Director and Head, Integrated Lead Discovery, Novartis Institutes for BioMedical Research

Mark Schurdak, Ph.D.
Research Associate Professor, Computational and Systems Biology, University of Pittsburgh; Director, Drug Discovery Institute

D. Lansing Taylor, Ph.D.
Director, University of Pittsburgh Drug Discovery Institute and Allegheny Foundation Professor, Computational and Systems Biology, University of Pittsburgh

Andreas Vogt, Ph.D.
Associate Professor, Computational and Systems Biology, University of Pittsburgh

Alan Waggoner, Ph.D.
Professor, Biological Sciences, and Director, Molecular Biosensor and Imaging Center, Carnegie Mellon University

Wei Zheng, Ph.D.
Group Leader, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health

晚餐会

2月10日 (水) 、18:00~21:00

高容量表型筛选入门

Instructor: Anthony M. Davies, Ph.D., Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

2月11日 (木) 、18:00~21:00

专家智库:如何满足具生理意义试验的需求?

Moderator: Lisa Minor, Ph.D., President, In Vitro Strategies, LLC

Choose your language
Chinese
Japanese
Korean
English

Catalog


产业会议汇总历
医疗设备相关国际会议

医疗设备相关国际会议

免费电子邮件通知服务
免费电子邮件通知服务